Cellular effects of hydroxyurea in Hb SC disease

British Journal of Haematology

Volumn 98, Issue 4, 1997, Pages 838-844

  Steinberg, Martin H ^a,d   Nagel, Ronald L ^b   Brugnara, Carlo ^c  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dense cells; Haemoglobin C; Haemoglobin SC disease; Hydroxyurea; Sickle haemoglobin

Indexed keywords

HEMOGLOBIN F; HYDROXYUREA;

ARTICLE; BLOOD CELL COUNT; BLOOD VOLUME; CELL DENSITY; CLINICAL ARTICLE; DRUG EFFECT; ERYTHROPOIESIS; HEMOGLOBIN SC DISEASE; HEMOLYSIS; HUMAN; PRIORITY JOURNAL;

EID: 0030768046     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3173132.x     Document Type: Article

References (46)

1. Ballas, S.K., Larner, J., Smith, E.D., Surrey, S., Schwartz, E. & Rappaport, E.F. (1987) The xerocytosis of Hb SC disease. Blood, 69, 124-130.
2. Benjamin, L.J., Berkowitz, L.R., Orringer, E.P., Mankad, V.N., Prasad, A.S., Lewkow, L.M., Chillar, R. & Peterson, C.M. (1986) A collaborative double-blind randomized study of cetiadil citrate in sickle cell crisis. Blood, 67, 1442-1447.
3. Berkowitz, L.R. & Orringer, E.P. (1981) Effect of cetiadil an in-vitro anti-sicking agent on erythrocyte membrane cation permeability. Journal of Clinical Investigation, 68, 1215-1220.
4. Betke, K., Marti, H.R. & Schlicht, I. (1959) Estimation of small percentages of foetal haemoglobin. Nature, 184, 1887-1888.
5. Bridges, K., Barabino, G., Brugnara, C., Cristoph, G., Cho, M., Dover, G., Eaton, W., Ewenstein, B., Golan, D., Guttman, C., Hofrichter, J., Mulkem, R. & Zhang, B. (1994) Hydroxyurea changes SS RKC biochemical/biophysical profile to that of SC RBCs. Blood, 84, 413a.
6. Brittain, H.A., Eckman, J.R., Swerlick, R.A., Howard, R.J. & Wick, T.M. (1993) Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood, 81, 2137-2143.
7. + channel: the imidazole ring is not required for inhibitory activity. Journal of Pharmacology and Experimental Therapeutics, 273, 266-272.
8. Brugnara, C., Bunn, H.F. & Tosteson, D.C. (1986) Regulation of erythrocyte cation and water content in sickle cell anemia. Science, 232, 388-390.
9. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. Journal of Clinical Investigation, 92, 520-526.
10. Brugnara, C., Kopin, A.S., Bunn, H.F. & Tosteson, D.C. (1985) Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease. Journal of Clinical Investigation, 75, 1608-1617.
11. Brugnara, C., Zelmanovic, D., Sorette, M., Ballas, S.K. & Platt, O. (1997) Reticulocyte hemoglobin: an integrated parameter for evaluation of erythropoietic activity. American Journal of Clinical Pathology, (in press).
12. Bunn, H.H. Noguchi, C.T., Hofrichter, J., Schechter, G.P. Schechter, A.N. & Eaton, W.A. (1982) Molecular and cellular pathogenesis of hemoglobin SC disease. Proceedings of the National Academy of Sciences of the United States of America, 79, 7527-7531.
13. Castro, O., Brambilla, D.J., Thorington, B., Reindorf, C.A., Scott, R.B., Gillette, P., Vera, J.C. & Levy, P.S., and Cooperative Study of Sickle Cell Disease (1994) The acute chest syndrome in sickle cell disease: Incidence and risk factors. Blood, 84, 643-649.
14. Charache, S., Barton, F.B., Moore, R.D., Terrin, M.L., Steinberg, M.H., Dover, G.J., Ballas, S.K., McMahon, R.P., Castro, O. & Orringer, E.P. (1996) Hydroxyurea and sickle cell anemia: clinical utility of a myelosuppressive 'switching' agent. Medicine (Baltimore), 75, 300-326.
15. Charache, S., Dover, G.J., Moore, R.D., Eckert, S., Ballas, S.K., Koshy, M., Milner, P.F.A., Orringer, E.P., Phillips, G., Jr. Platt, O.S. & Thomas, G.H. (1992) Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood, 79, 2555-2565.
16. Charache, S., Dover, G.J., Moyer, M.A. & Moore, J.W. (1987) Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. Blood, 69, 109-116.
17. Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V. McMahon, R.P., Bonds, D.R., and Multicenter Study of Hydroxyurea in Sickle Cell Anemia (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. New England Journal of Medicine, 332, 1317-1322.
18. Clark, M.R., Mohandas, N. & Shohet, S.B. (1982) Hydration of sickle cells using the sodium ionophore Monesin: a model for therapy. Journal of Clinical Investigation, 70, 1074-1080.
19. Dover, G.J., Humphries, R.K., Moore, J.G., Ley, T.J., Young, N.S., Charache, S. & Nienhuis, A.W. (1986) Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production. Blood, 67, 735-738.
20. Fabry, M.E., Kaul, D.K., Raventos-Suarez, C., Chang, H. & Nagel, R.L. (1982) SC cells have an abnormally high intracellular hemoglobin concentration: pathophysiologlcal consequences. Journal of Clinical Investigation, 70, 1315-1319.
21. Gee, B.E. & Platt, O.S. (1995) Sickle reticulocytes adhere to VCAM-1. Blood, 85, 268-274.
22. Hebbel, R.P., Boogaerts, M.A., Eaton, J.W. & Steinberg, M.H. (1980) Erythrocyte adherence to endothelium in sickle-cell anemia: a possible determinant of disease severity. New England Journal of Medicine, 302, 992-995.
23. Horiuchi, K., Hirokawa, K.J., Chomo, M.J. & Ohene-Frempong, K. (1996) Hydroxyurea inhibits in vitro sickling of reticulocytes. (Abstract). Blood, 88, 495A.
24. 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood, 82, 3548-3555.
25. Kinney, T.R. & Ware, R.E. (1994) Compound heterozygous states. Sickle Cell Disease: Basic Principles and Clinical Practice (ed. by S. H. Embury, R. P. Hebbel, N. Mohandas and M. H. Steinberg), p. 437, Raven Press, New York.
26. Lawrence, C., Fabry, M.E. & Nagel, R.L. (1991) The unique red cell heterogeneity of SC disease: crystal formation, dense reticulocytes, and unusual morphology. Blood, 78, 2104-2112.
27. Lutty, G.A. & Goldberg, M.F. (1994) Ophthalmologic complications. Sickle Cell Disease: Basic Principles and Clinical Practice (ed. by S. H. Embury, R. P. Hebbel, N. Mohandas and M. H. Steinberg), p. 703, Raven Press, New York.
28. Milner, P.F., Kraus, A.P., Sebes, J.I., Sleeper, L.A., Dukes, K.A., Embury, S.H., Bellevue, R., Koshy, M., Moohr, J.W. & Smith, J. (1991) Sickle cell disease as a cause of osteonecrosis of the femoral head. New England Journal of Medicine, 325, 1476-1481.
29. Mohandas, N., Kim, Y.R., Tycko, D.H., Orlik, J., Wyatt, J. & Groner, W. (1986) Accurate and independent measurement of volume and hemoglobin concentration of individual cells by laser light scattering. Blood, 68, 506-513.
30. Motulsky, A.G. (1973) Frequency of sickling disorders in US blacks. New England Journal of Medicine, 288, 31-33.
31. Nagel, R.L. & Lawrence, C. (1991) The distinct pathobiology of sickle cell-hemoglobin C disease: therapeutic implications. Hematology/Oncology Clinics of North America, 5, 433-451.
32. Noguchi, C.T., Dover, G.J., Rodgers, G.P., Serjeant, G.R., Antonarakis, S.E., Anagnou, N.P., Higgs, D.R., Weatherall, D.J. & Schechter, A.N. (1985) Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease. Journal of Clinical Investigation, 75, 1632-1637.
33. Orringer, E.P., Blythe, D.S.B., Johnson, A.E., Phillips, G., Jr. Dover, G.J. & Parker, J.C. (1991a) Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia. Blood, 78, 212-216.
34. Orringer, E.P., Brockenbrough, J.S., Whitney, J.A., Glosson, P.S. & Parker, J.C. (1991b) Okadaic acid inhibits activation of K-Cl cotransport in red blood cells containing hemoglobins S and C. American Journal of Physiology (Cellular Physiology), 261, C591-C593.
35. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease: life expectancy and risk factors for early death. New England Journal of Medicine, 330, 1639-1644.
36. Platt, O.S., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E. & Kinney, T.R. (1991) Pain in sickle cell disease: rates and risk factors. New England Journal of Medicine, 325, 11-16.
37. Rodgers, G.P., Dover, G.J., Noguchi, C.T., Schlechter, A.N. & Nienhuis, A.W. (1990) Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. New England Journal of Medicine, 122, 1037-1045.
38. Steinberg, M.H. (1996) Modulation of the phenotypic diversity of sickle cell anemia. Hemoglobin, 20, 1-19.
39. Steinberg, M.H., Coleman, M.B., Adams, J.G., Platica, O., Gillette, P. & Rieder, R.F. (1983) The effects of alphu-thalassaemia in HbSC disease. British Journal of Haematology, 55, 487-492.
40. Steinberg, M.H., Hsu, H., Nagel, R.L., Milner, P.F., Adams, J.G., Benjamin, L., Fryd, S., Gillette, P., Gilman, J., Josifovska, O., Hellman-Erlingsson, S., Safaya, S., Huey, L., & Rieder, R.F. (1995) Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. American Journal of Hematology, 48, 175-181.
41. Steinberg, M.H., Lu, Z.-H., Barton, F.B., Terrin, M.L., Charache, S. & Dover, G.J., and Multicenter Study of Hydroxyurea (1997) Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Blood, 89, 1078-1088.
42. Steinberg, M.H., Nagel, R.L., Lawrence, C., Swaminathan, V., Lu, Z.-H., Plonczynski, M. & Harrell, A. (1996) β-Globin gene haplotype in Hb SC disease. American Journal of Hematology, 52, 189-191.
43. + sickle reticulocytes to endothelial cells. Blood, 80, 2634-2642.
44. 1-Integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood, 82, 1891-1899.
45. Wick, T.M., Moake, J.L., Udden, M.M. & McIntire, L.V. (1993) Unusually large von Willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells. American Journal of Hematology, 42, 284-292.
46. + channel of Hb A and Hb S red cells: individual differences in the number of channels. Journal of Membrane Biology, 106, 276-281.